“…While the earliest work was rightly centred on the fundamental science of delivery and understanding of the resulting physiological effects, recent years have seen enhanced emphasis on translation to patient benefit and commercial return, with several notable companies making progress towards commercialisation. Indeed, a number of studies examining patient usability (Birchall et al, 2011, Donnelly et al, 2014a, Vicente-Pérez et al, 2016), scaled-up manufacture and quality control testing (Larrañeta et al, 2015, Larrañeta et al, 2016b, Lutton et al, 2015b), sterile production (McCrudden et al, 2015a) and regulatory considerations (Lutton et al, 2015a) have now been published. MN with applications in improving skin appearance are now available commercially, though it is notable that these are not approved drug products (McCrudden et al, 2015b).…”